Off-label Medical

Reimbursed Care Access in Argentina

Argentina has an established regulatory framework for specific psychedelic derivatives, specifically Esketamine, while maintaining strict prohibition for classic hallucinogens like Psilocybin and MDMA.

Psilocybin

Strictly Illegal

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research.

Read Psilocybin Overview

Esketamine

Approved / Private Coverage

Spravato (esketamine nasal spray) was approved by the National Administration of Medicines, Food and Medical Technology (ANMAT) in April 2021 for treatment-resistant depression #. Coverage is currently primarily through private health insurance (prepagas) and specific medical exceptions.

Read Esketamine Overview

Ketamine

Legal Medical Use

Ketamine is strictly regulated and authorized for anesthetic and analgesic use in hospital settings. Off-label use for psychiatric conditions is emerging in private clinics but is not standardly reimbursed.

Read Ketamine Overview

Looking for Clinical Trials?

There are currently 8 active clinical trials investigating psychedelics in Argentina.

View Active Trials